MPR- Medical Professionals Reference
@medicalprofref.bsky.social
MPR provides daily drug news and industry-supported drug information & education. Download our drug reference and clinical tools app today!
October 2025 Drug Approvals: Our at-a-glance essential prescribing update. ➡️ www.empr.com/news/october...
November 14, 2025 at 9:14 PM
October 2025 Drug Approvals: Our at-a-glance essential prescribing update. ➡️ www.empr.com/news/october...
Get yourself up to date on Lynkuet — a treatment approved for vasomotor symptoms due to menopause — with our InsightRx interview with trial investigator Dr JoAnn Pinkerton. www.empr.com/news/lynkuet...
November 12, 2025 at 8:42 PM
Get yourself up to date on Lynkuet — a treatment approved for vasomotor symptoms due to menopause — with our InsightRx interview with trial investigator Dr JoAnn Pinkerton. www.empr.com/news/lynkuet...
Current evidence for the use of leucovorin to treat autism symptoms is mainly limited to small studies and case reports in children with CFD.
www.empr.com/news/aap-cur...
www.empr.com/news/aap-cur...
October 31, 2025 at 5:36 PM
Current evidence for the use of leucovorin to treat autism symptoms is mainly limited to small studies and case reports in children with CFD.
www.empr.com/news/aap-cur...
www.empr.com/news/aap-cur...
Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. www.empr.com/news/moderna...
October 23, 2025 at 8:07 PM
Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. www.empr.com/news/moderna...
Drug combo gets Priority Review for possible adjuvant treatment in patients with muscle-invasive bladder cancer. www.empr.com/news/enfortu...
October 22, 2025 at 8:01 PM
Drug combo gets Priority Review for possible adjuvant treatment in patients with muscle-invasive bladder cancer. www.empr.com/news/enfortu...
Participants in a social anxiety treatment trial were tasked with delivering a 5 minutes speech with 2 minutes notice. The results did not match the primary endpoint. www.empr.com/news/negativ...
October 21, 2025 at 3:37 PM
Participants in a social anxiety treatment trial were tasked with delivering a 5 minutes speech with 2 minutes notice. The results did not match the primary endpoint. www.empr.com/news/negativ...
A psychedelic nasal spray has been designated a Breakthrough therapy by the FDA. www.empr.com/news/intrana...
October 17, 2025 at 7:30 PM
A psychedelic nasal spray has been designated a Breakthrough therapy by the FDA. www.empr.com/news/intrana...
Jascayd was recently approved to treat idiopathic pulmonary fibrosis, we spoke to one of the trial investigators it in our latest InsightRx. www.empr.com/news/jascayd...
October 17, 2025 at 6:55 PM
Jascayd was recently approved to treat idiopathic pulmonary fibrosis, we spoke to one of the trial investigators it in our latest InsightRx. www.empr.com/news/jascayd...
Rhapsido was recently approved for chronic spontaneous urticaria, find out all about it from one of the clinical trial investigators on MPR's InsightRx. www.empr.com/news/rhapsid...
October 10, 2025 at 5:09 PM
Rhapsido was recently approved for chronic spontaneous urticaria, find out all about it from one of the clinical trial investigators on MPR's InsightRx. www.empr.com/news/rhapsid...
Immunization schedule changes approved for COVID-19 vaccines. www.empr.com/news/cdc-app...
October 7, 2025 at 6:19 PM
Immunization schedule changes approved for COVID-19 vaccines. www.empr.com/news/cdc-app...
Potential treatment for autosomal dominant polycystic kidney disease gains Fast Track status. www.empr.com/news/fda-fas...
October 2, 2025 at 8:07 PM
Potential treatment for autosomal dominant polycystic kidney disease gains Fast Track status. www.empr.com/news/fda-fas...
Tremfya gets OK'd for patients 6 years and older. www.empr.com/news/tremfya...
September 29, 2025 at 8:01 PM
Tremfya gets OK'd for patients 6 years and older. www.empr.com/news/tremfya...
🎧 Latest MPR Pod out now and its been a week!
🔹 CDC recs changes to MMRV vax;
🔸 Trump admin make acetaminophen-autism claim;
🔹 Barth syndrome Tx gets green light;
🔸 Breakthrough in Huntington disease; and
🔹 SC formulation of Keytruda.
www.empr.com/news/mpr-wee...
🔹 CDC recs changes to MMRV vax;
🔸 Trump admin make acetaminophen-autism claim;
🔹 Barth syndrome Tx gets green light;
🔸 Breakthrough in Huntington disease; and
🔹 SC formulation of Keytruda.
www.empr.com/news/mpr-wee...
September 26, 2025 at 7:52 PM
🎧 Latest MPR Pod out now and its been a week!
🔹 CDC recs changes to MMRV vax;
🔸 Trump admin make acetaminophen-autism claim;
🔹 Barth syndrome Tx gets green light;
🔸 Breakthrough in Huntington disease; and
🔹 SC formulation of Keytruda.
www.empr.com/news/mpr-wee...
🔹 CDC recs changes to MMRV vax;
🔸 Trump admin make acetaminophen-autism claim;
🔹 Barth syndrome Tx gets green light;
🔸 Breakthrough in Huntington disease; and
🔹 SC formulation of Keytruda.
www.empr.com/news/mpr-wee...
Gene therapy demonstrates success in Huntington disease, slowing disease progression by 75%. www.empr.com/news/gene-th...
September 24, 2025 at 7:56 PM
Gene therapy demonstrates success in Huntington disease, slowing disease progression by 75%. www.empr.com/news/gene-th...
Large studies have shown that COVID-19 vaccines are safe in pregnancy, yet the new vaccine advisory group say they will review safety. www.empr.com/news/us-offi...
September 17, 2025 at 2:34 PM
Large studies have shown that COVID-19 vaccines are safe in pregnancy, yet the new vaccine advisory group say they will review safety. www.empr.com/news/us-offi...
💊 Need a recap of drugs in the pipeline updates from August? We got you covered: www.empr.com/news/august-...
September 15, 2025 at 7:13 PM
💊 Need a recap of drugs in the pipeline updates from August? We got you covered: www.empr.com/news/august-...
View all the drug approval decisions expected to take place in October. www.empr.com/news/fda-dru...
September 9, 2025 at 8:00 PM
View all the drug approval decisions expected to take place in October. www.empr.com/news/fda-dru...
Findings from the trial reinforce data supporting the approval of the LP.8.1-adapted COVID-19 vaccine for the upcoming season. www.empr.com/news/pfizer-...
September 8, 2025 at 8:51 PM
Findings from the trial reinforce data supporting the approval of the LP.8.1-adapted COVID-19 vaccine for the upcoming season. www.empr.com/news/pfizer-...
The AAP has published a pediatric immunization schedule that differs from the CDC's recent recommendations. www.empr.com/news/aap-rel...
August 19, 2025 at 7:35 PM
The AAP has published a pediatric immunization schedule that differs from the CDC's recent recommendations. www.empr.com/news/aap-rel...
Weight loss drug gains noncirrhotic MASH indication. www.empr.com/news/wegovy-...
August 19, 2025 at 4:38 PM
Weight loss drug gains noncirrhotic MASH indication. www.empr.com/news/wegovy-...
The American Heart Association updated blood pressure guidelines to include the PREVENT risk calculator, which combines measures of cardiovascular, kidney, and metabolic health to estimate disease risk. www.empr.com/news/aha-acc...
August 18, 2025 at 3:05 PM
The American Heart Association updated blood pressure guidelines to include the PREVENT risk calculator, which combines measures of cardiovascular, kidney, and metabolic health to estimate disease risk. www.empr.com/news/aha-acc...
FDA to review Bluejepa as possible treatment for uncomplicated urogenital gonorrhea. www.empr.com/news/gepotid...
August 11, 2025 at 8:11 PM
FDA to review Bluejepa as possible treatment for uncomplicated urogenital gonorrhea. www.empr.com/news/gepotid...
Orally administered HER2-mutant non-small cell lung cancer treatment gains FDA approval. www.empr.com/news/hernexe...
August 11, 2025 at 5:52 PM
Orally administered HER2-mutant non-small cell lung cancer treatment gains FDA approval. www.empr.com/news/hernexe...
🎧 New MPR Pod out now!
⚕️ Label change for opioids;
💊 Positive results for oral GLP-1;
🤕 Migraine prevention Tx approved for children;
🔸 Restrictions removed for Ixchiq vaccines; and
🔹 Modeyso approved for rare brain tumor.
www.empr.com/news/mpr-wee...
⚕️ Label change for opioids;
💊 Positive results for oral GLP-1;
🤕 Migraine prevention Tx approved for children;
🔸 Restrictions removed for Ixchiq vaccines; and
🔹 Modeyso approved for rare brain tumor.
www.empr.com/news/mpr-wee...
August 7, 2025 at 8:21 PM
🎧 New MPR Pod out now!
⚕️ Label change for opioids;
💊 Positive results for oral GLP-1;
🤕 Migraine prevention Tx approved for children;
🔸 Restrictions removed for Ixchiq vaccines; and
🔹 Modeyso approved for rare brain tumor.
www.empr.com/news/mpr-wee...
⚕️ Label change for opioids;
💊 Positive results for oral GLP-1;
🤕 Migraine prevention Tx approved for children;
🔸 Restrictions removed for Ixchiq vaccines; and
🔹 Modeyso approved for rare brain tumor.
www.empr.com/news/mpr-wee...
View all the drug approval decisions expected to take place in September. www.empr.com/news/fda-dru...
August 4, 2025 at 8:13 PM
View all the drug approval decisions expected to take place in September. www.empr.com/news/fda-dru...